Graeme Martin
InvestorVenture Partner at ALSA Ventures · Executive Chairman at Pro Matix
United Kingdom
Find your path to Graeme
289 people in our graph share verified history with Graeme — schools, employers, funds. One of them is your warm intro.
Mike FitzgeraldunlockedGraeme: together at Roche (2001)
Graeme: together at Montis Biosciences
×3Graeme: together at Roche
×7Graeme: together at University of Bath
About
Graeme has a forty-year career in pharma and biotech across Europe, the USA and Japan, with senior R&D roles at Roche, GSK and Wellcome, and served as President and CEO of Takeda Ventures. He holds a BSc and PhD in Pharmacology.
Executive Chairman at Pro Matix
Intro paths
→
In turn, Graeme can intro founders to Pro Matix's investors below.
Pro Matix's investors · 1
Experience
- Promatix Biosciences LtdExecutive Chairpersoncurrent2025 — present
- Promatix Biosciences LtdNon Executive Directorcurrent2024 — present
- Vantage BiosciencesNon Executive Directorcurrent2024 — present
- ALSA VenturesBoard Member / Consultantcurrent2024 — presentLondon Area, United Kingdom
- ALSA VenturesChief Investment Officer2019 — 2024London, England, United Kingdom
- BioNeexMember Of The Board Of Advisorscurrent2022 — present
- Montis BiosciencesNon Executive Directorcurrent2022 — present
- Harrington Discovery Institute at University HospitalsHarrington Discovery Institute Investment Advisorcurrent2019 — presentCleveland, Ohio, United States
- ARJUNA TherapeuticsNon Executive Directorcurrent2018 — presentLondon, England, United Kingdom
- HatchBox Bioconsulting LLCPrincipalcurrent2017 — presentBay Area, CA, USA
- DJS AntibodiesChairperson2018 — 2022Oxford, England, United Kingdom
- Scioto Biosciences, IncNon Executive Director2018 — 2020Indianapolis, Indiana, United States
- 3Brain AGNon Executive Director2017 — 2019Wädenswil, Zurich, Switzerland
- Takeda Ventures, Inc.President & CEO2003 — 2017Palo Alto, CA, USA
- RocheVice President, CNS Therapeutic Area1996 — 2001Palo Alto, CA, USA
Skills & more
Drug Discovery39Biotechnology56Technology Transfer27Lifesciences15Clinical Development41Pharmaceutical Industry46Biochemistry1Biopharmaceuticals18ManagementResearch and Development (R&D)Oncology1Therapeutic Areas
+8 more
CommercializationRegulatory AffairsStrategic PartnershipsStrategic ThinkingStrategic ConsultingBusiness StrategyCancer TherapeuticsTherapeutic ModalitiesFrom Graeme's professional profile.
Colleagues at ALSA Ventures
Alek Safarian
CEO at ALSA Ventures
Andre Badalyan
Senior Analyst at ALSA Ventures
Bruce Goldsmith
Operating Partner at ALSA Ventures
Gerard Evan
Advisor at ALSA Ventures
Jasmin Fisher
Advisor at ALSA Ventures
Julia Jones
Investment Manager at ALSA Ventures
Jyoti Choudhary
Advisor at ALSA Ventures
Katie Sunnucks
Associate at ALSA Ventures
Frequently asked questions
- Who is Graeme Martin?
- Graeme has a forty-year career in pharma and biotech across Europe, the USA and Japan, with senior R&D roles at Roche, GSK and Wellcome, and served as President and CEO of Takeda Ventures. He holds a BSc and PhD in Pharmacology.
- Where does Graeme Martin work?
- Graeme Martin is Venture Partner at ALSA Ventures and Executive Chairman at Pro Matix.
- Where did Graeme Martin go to school?
- Graeme Martin studied at UCL (Ph.D., Pharmacology); University of Bath (B.Sc., Pharmacology); UCL (Ph.D., Pharmacology).
Same school
Also attended UCL630
Demis HassabisCo-founder & CEO of Google DeepMindAndré DuboisInvestor at Index VenturesFrédérique DameInvestor at GV (Google Ventures)Jonas VetterleInvestor at Moonfire VenturesMarie FerriInvestor at DaphniElena PantaziPartner & Head of Platform at Northzone
+ 624 more
Also attended University of Bath194
Catherine BergersenSenior Executive Assistant at Mayfair Equity PartnersJohanInvestor at InvestinorMaddie CoughlinInvestor at DN CapitalBen PalmerInvestment Professional at OxxJuliette PetitChief of Staff at Keen Venture PartnersSarah HollyheadDirector at Marlin Equity Partners
+ 188 more
Shared employers
Also worked at ALSA Ventures7
Alek SafarianCEO at ALSA VenturesLorna CollingsCFO at ALSA VenturesRobert BalfourInvestment Director at ALSA VenturesJulia JonesInvestment Manager at ALSA VenturesKatie SunnucksAssociate at ALSA VenturesAndre BadalyanSenior Analyst at ALSA Ventures
+ 1 more
